MedPath

Epinephrine

Generic Name
Epinephrine
Brand Names
Adrenalin, Allerject, Anapen, Articadent, Astracaine, Auvi-Q, Citanest, Citanest Forte, Emerade, Epipen, Lignospan, Marcaine, Marcaine With Epinephrine, Octocaine, Octocaine With Epinephrine, Orabloc, Scandonest, Sensorcaine, Sensorcaine With Epinephrine, Septanest, Septocaine, Symjepi, Ultacan, Ultracaine, Vivacaine, Xylocaine, Xylocaine With Epinephrine, Zorcaine, Eurneffy
Drug Type
Small Molecule
Chemical Formula
C9H13NO3
CAS Number
51-43-4
Unique Ingredient Identifier
YKH834O4BH

Overview

Epinephrine, also known as adrenaline, is a hormone and neurotransmitter and produced by the adrenal glands that can also be used as a drug due to its various important functions. Though it has long been used in the treatment of hypersensitivity reactions, epinephrine in the auto-injector form (EpiPen) has been available since 1987 in the USA. Many new products/biosimilars and dosage routes have been approved under various names over the last several decades , , . On August 16, 2018, Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths . Dosage delivery routes for epinephrine include intravenous, inhalation, nebulization, intramuscular injection, and subcutaneous injection. In general, the most common uses of parenteral epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity (anaphylactic or anaphylactoid) reactions to drugs, animal serums and other allergens, and to prolong the action of infiltration anesthetics . In addition to the above functions, epinephrine is the primary drug administered during cardiopulmonary resuscitation (CPR) to reverse cardiac arrest , . It can be used in severe cases of croup .

Background

Epinephrine, also known as adrenaline, is a hormone and neurotransmitter and produced by the adrenal glands that can also be used as a drug due to its various important functions. Though it has long been used in the treatment of hypersensitivity reactions, epinephrine in the auto-injector form (EpiPen) has been available since 1987 in the USA. Many new products/biosimilars and dosage routes have been approved under various names over the last several decades , , . On August 16, 2018, Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths . Dosage delivery routes for epinephrine include intravenous, inhalation, nebulization, intramuscular injection, and subcutaneous injection. In general, the most common uses of parenteral epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity (anaphylactic or anaphylactoid) reactions to drugs, animal serums and other allergens, and to prolong the action of infiltration anesthetics . In addition to the above functions, epinephrine is the primary drug administered during cardiopulmonary resuscitation (CPR) to reverse cardiac arrest , . It can be used in severe cases of croup .

Indication

Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. Epinephrine's cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes but is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock . Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of local anesthetics . In addition to the above, epinephrine is used as an over the counter (OTC) agent for the intermittent symptoms of asthma, such as wheezing, tightness of chest and shortness of breath . It is also used for the maintenance of mydriasis during intraocular surgery .

Associated Conditions

  • Anaphylaxis
  • Angioneurotic Edema
  • Bleeding
  • Bronchospasm
  • Complete Heart Block
  • Hypotension
  • Idiopathic Anaphylaxis
  • Laryngotracheobronchitis
  • Mild Intermittent Asthma
  • Nasal Congestion
  • Open Angle Glaucoma (OAG)
  • Respiratory Distress
  • Severe Asthma
  • Syncope
  • Type I Hypersensitivity
  • Urticaria
  • Uterine Contractions
  • Ventricular Fibrillation
  • Resuscitation in cardiac arrest following anesthetic accidents
  • Severe hypersensitivity reactions
  • Unresponsive Asystole
  • Unresponsive Bradycardia

FDA Approved Products

Lidocaine Hydrochloride and Epinephrine
Manufacturer:Hospira, Inc.
Route:EPIDURAL, INFILTRATION, PERINEURAL, INTRACAUDAL
Strength:5 ug in 1 mL
Approved: 2022/09/14
NDC:0409-3183
EPINEPHRINE
Manufacturer:HF Acquisition Co LLC, DBA HealthFirst
Route:INTRAVENOUS
Strength:0.1 mg in 1 mL
Approved: 2024/01/22
NDC:51662-1629
Lidocaine Hydrochloride and Epinephrine Bitartrate
Manufacturer:IQ Dental
Route:SUBMUCOSAL
Strength:0.01 mg in 1 mL
Approved: 2024/02/08
NDC:42756-1030
Marcaine with Epinephrine
Manufacturer:Hospira, Inc.
Route:PERINEURAL
Strength:0.0091 mg in 1 mL
Approved: 2022/01/14
NDC:0409-1755
Epinephrine
Manufacturer:REMEDYREPACK INC.
Route:INTRAMUSCULAR
Strength:0.15 mg in 0.3 mL
Approved: 2024/02/23
NDC:70518-1910

Singapore Approved Products

ADRENALINE AGUETTANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.1 MG/ML
Manufacturer:Laboratoire AGUETTANT
Form:INJECTION, SOLUTION
Strength:0.1 mg/ml
Online:Yes
Approved: 2023/11/07
Approval:SIN16897P
XYLOCAINE 2% WITH ADRENALINE 1:80,000 INJECTION
Manufacturer:Showa Yakuhin Kako Co.,Ltd.
Form:INJECTION
Strength:0.0125 mg/ml
Online:Yes
Approved: 1991/04/08
Approval:SIN05752P
XYLESTESIN-A INJECTION
Manufacturer:3M Deutschland GmbH
Form:INJECTION
Strength:0.0125 mg/ml
Online:Yes
Approved: 1991/05/08
Approval:SIN06177P
Posicaine-100 Injection
Manufacturer:Novocol Pharmaceutical of Canada Inc.
Form:INJECTION, SOLUTION
Strength:0.01mg/ml
Online:Yes
Approved: 2014/04/10
Approval:SIN14537P
EpiPen Junior (Epinephrine) Auto-Injector 0.15mg/dose (0.5mg/ml)
Manufacturer:Meridian Medical Technologies, Inc.
Form:INJECTION
Strength:0.5 mg/ml
Online:Yes
Approved: 2007/06/07
Approval:SIN13290P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath